These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2984099)

  • 1. Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening.
    Schulte HM; Chrousos GP; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    Horm Res; 1985; 21(2):69-74. PubMed ID: 2984099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of plasma adrenocorticotropin and cortisol to intravenous injection of synthetic ovine corticotropin releasing factor in the morning and early evening in normal human subjects.
    Watabe T; Tanaka K; Hasegawa M; Miyabe S; Shimizu N
    Endocrinol Jpn; 1985 Oct; 32(5):771-9. PubMed ID: 3004929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary and adrenal responses to pulsatile ovine corticotropin-releasing factor administered to fetal sheep.
    Brooks AN; Challis JR; Norman LJ
    Endocrinology; 1987 Jun; 120(6):2383-8. PubMed ID: 3032589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma adrenocorticotropin and cortisol responses to intravenous injection of corticotropin-releasing factor in the morning and evening.
    Tsukada T; Nakai Y; Koh T; Tsujii S; Imura H
    J Clin Endocrinol Metab; 1983 Oct; 57(4):869-71. PubMed ID: 6309891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications.
    Schulte HM; Chrousos GP; Gold PW; Booth JD; Oldfield EH; Cutler GB; Loriaux DL
    J Clin Invest; 1985 Jun; 75(6):1781-5. PubMed ID: 2989331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and adrenal responses to ovine corticotropin releasing factor and vasopressin injected into young and adult guinea-pigs.
    Pradier P; Tournaire C; Dalle M
    J Dev Physiol; 1990 Sep; 14(3):163-9. PubMed ID: 1966108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ovine corticotropin-releasing hormone on adrenocorticotropin secretion in the absence of glucocorticoid feedback inhibition in man.
    Debold CR; Jackson RV; Kamilaris TC; Sheldon WR; Decherney GS; Island DP; Orth DN
    J Clin Endocrinol Metab; 1989 Feb; 68(2):431-7. PubMed ID: 2537333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diurnal variation in the response of plasma adrenocorticotropin and cortisol to intravenous ovine corticotropin-releasing hormone.
    DeCherney GS; DeBold CR; Jackson RV; Sheldon WR; Island DP; Orth DN
    J Clin Endocrinol Metab; 1985 Aug; 61(2):273-9. PubMed ID: 2989316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hormonal actions of corticotropin-releasing factor in sheep: effect of intravenous and intracerebroventricular injection.
    Donald RA; Redekopp C; Cameron V; Nicholls MG; Bolton J; Livesey J; Espiner EA; Rivier J; Vale W
    Endocrinology; 1983 Sep; 113(3):866-70. PubMed ID: 6307669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACTH and cortisol responses to ovine corticotrophin-releasing factor in patients with primary and secondary adrenal failure.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    Clin Endocrinol (Oxf); 1985 Jun; 22(6):761-9. PubMed ID: 2990763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACTH responses to CRF and AVP in pregnant and nonpregnant ewes.
    Keller-Wood M
    Am J Physiol; 1998 Jun; 274(6):R1762-8. PubMed ID: 9841549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing factor (ovine) and vasopressin exert a synergistic effect on adrenocorticotropin release in man.
    Lamberts SW; Verleun T; Oosterom R; de Jong F; Hackeng WH
    J Clin Endocrinol Metab; 1984 Feb; 58(2):298-303. PubMed ID: 6319446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia.
    Engler D; Pham T; Fullerton MJ; Ooi G; Funder JW; Clarke IJ
    Neuroendocrinology; 1989 Apr; 49(4):367-81. PubMed ID: 2541360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of synthetic ovine corticotropin-releasing factor. Dose response of plasma adrenocorticotropin and cortisol.
    Orth DN; Jackson RV; DeCherney GS; DeBold CR; Alexander AN; Island DP; Rivier J; Rivier C; Spiess J; Vale W
    J Clin Invest; 1983 Mar; 71(3):587-95. PubMed ID: 6298280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cortisol infusion on basal and corticotropin-releasing factor (CRF)-stimulated plasma ACTH concentrations in the sheep fetus after surgical isolation of the pituitary.
    Ozolins IZ; Young IR; McMillen IC
    Endocrinology; 1990 Oct; 127(4):1833-40. PubMed ID: 2169403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep.
    McFarlane A; Coghlan J; Tresham J; Wintour EM
    Endocrinology; 1995 May; 136(5):1821-7. PubMed ID: 7720626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
    Tizabi Y; Aguilera G
    Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin releasing factor: basic studies and clinical applications.
    Chrousos GP; Calabrese JR; Avgerinos P; Kling MA; Rubinow D; Oldfield EH; Schuermeyer T; Kellner CH; Cutler GB; Loriaux DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):349-59. PubMed ID: 2999871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
    Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
    J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.